Authors
Howell, AnthonyAffiliation
CRC Department of Medical Oncology, University of Manchester, Christie Hospital, UK.Issue Date
2000
Metadata
Show full item recordCitation
Tamoxifen versus the newer SERMs: what is the evidence? 2000, 11 Suppl 3:255-65 Ann. Oncol.Journal
Annals of OncologyPubMed ID
11079150Type
ArticleLanguage
enISSN
0923-7534Collections
Related articles
- Clinical use of selective estrogen receptor modulators and down regulators with the main focus on breast cancer.
- Authors: Baumann CK, Castiglione-Gertsch M
- Issue date: 2009 Dec
- The use of selective estrogen receptor modulators and selective estrogen receptor down-regulators in breast cancer.
- Authors: Howell SJ, Johnston SR, Howell A
- Issue date: 2004 Mar
- Selective estrogen receptor modulators (SERMS) and their roles in breast cancer prevention.
- Authors: Park WC, Jordan VC
- Issue date: 2002 Feb
- [Selective estrogen receptors modulators (SERMs): biochemistry, pharmacology, and clinical use in gynecology].
- Authors: Terán Dávila J, Teppa Garrán AD
- Issue date: 2005 Aug
- The selective estrogen receptor modulators in breast cancer prevention.
- Authors: Li F, Dou J, Wei L, Li S, Liu J
- Issue date: 2016 May